home / stock / cmpx / cmpx short
Short Information | Compass Therapeutics Inc. (OTCMKTS:CMPX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 62,840 |
Total Actual Volume | 95,076 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 12 |
No Change Days | 4 |
Averages | |
---|---|
Average Short Volume | 3,142 |
Average Short Percentage | 63.28% |
Is there a CMPX Short Squeeze or Breakout about to happen?
See the CMPX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
10-29-2021 | $3 | $3.02 | $3.02 | $3 | 1,875 | 455 | 24.27% |
10-28-2021 | $2.9 | $3 | $3.03 | $2.9 | 5,612 | 2,612 | 46.54% |
10-27-2021 | $3 | $2.9 | $3.01 | $2.9 | 2,970 | 2,450 | 82.49% |
10-26-2021 | $3.1325 | $3 | $3.1325 | $2.01 | 20,455 | 8,465 | 41.38% |
10-25-2021 | $3.25 | $3.15 | $3.25 | $3.08 | 6,627 | 5,500 | 82.99% |
10-19-2021 | $3.25 | $3.25 | $3.25 | $3.25 | 2,028 | 2,028 | 100% |
10-18-2021 | $3.21 | $3.2 | $3.21 | $3.16 | 11,920 | 9,120 | 76.51% |
10-14-2021 | $3.16 | $3.17 | $3.18 | $3.16 | 2,487 | 1,000 | 40.21% |
10-13-2021 | $3.2 | $3.16 | $3.2 | $3.16 | 1,092 | 200 | 18.32% |
10-12-2021 | $3.35 | $3.25 | $3.35 | $3.21 | 15,200 | 14,000 | 92.11% |
10-08-2021 | $3.51 | $3.4 | $3.51 | $3.4 | 3,042 | 140 | 4.6% |
10-07-2021 | $3.35 | $3.51 | $3.51 | $3.35 | 13,909 | 11,309 | 81.31% |
10-06-2021 | $3.5 | $3.3 | $3.5 | $3.3 | 1,309 | 100 | 7.64% |
10-05-2021 | $3.51 | $3.5 | $3.51 | $3.5 | 1,962 | 1,184 | 60.35% |
09-30-2021 | $3.51 | $3.41 | $3.51 | $3.41 | 332 | 222 | 66.87% |
09-23-2021 | $3.55 | $3.5 | $3.55 | $3.5 | 335 | 135 | 40.3% |
09-22-2021 | $3.55 | $3.55 | $3.55 | $3.55 | 293 | 292 | 99.66% |
09-21-2021 | $3.55 | $3.55 | $3.55 | $3.55 | 3,000 | 3,000 | 100% |
09-20-2021 | $3.55 | $3.55 | $3.55 | $3.55 | 328 | 328 | 100% |
09-17-2021 | $3.55 | $3.55 | $3.55 | $3.55 | 300 | 300 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Compass Therapeutics Inc. Company Name:
CMPX Stock Symbol:
OTCMKTS Market:
Compass Therapeutics Inc. Website:
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside cha...
BOSTON, May 28, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its Board of Directors has appointed Thomas Sc...
CTX-471, a novel anti-CD137 agonist antibody, demonstrated anti-tumor activity in the Company’s Phase 1 Dose Escalation and Dose Expansion, first-in-human monotherapy study in patients with metastatic or locally advanced malignancies who had progressed on approved PD-1 or PD-L1 inhibitors....